Back to search

Article

Selective Inactivation of Astrocytic Monoacylglycerol Lipase for Alzheimer’s Disease Therapy

2025-12-09

Abstract excerpt

Alzheimer’s disease (AD) is the leading cause of dementia in the elderly, yet effective therapies remain lacking. Here, we identify monoacylglycerol lipase (MAGL), the principal enzyme that degrades the endocannabinoid 2-arachidonoylglycerol (2-AG) in the brain, specifically in astrocytes as a promising therapeutic target for AD. APP transgenic (TG) mice with astrocyte-specific MAGL deletion (TG-aKO), but not neur...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d859e668-dec5-56fe-a990-80c9faba6d81
DOI
10.64898/2025.12.04.692105
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Selective Inactivation of Astrocytic Monoacylglycerol Lipase for Alzheimer’s Disease TherapyDOI 10.64898/2025.12.04.692105
Select a neighboring publication to make it the new centre.